Crohn's & Colitis Foundation Inc logo

Crohn's & Colitis Foundation Inc

NEW YORK, NY EIN: 13-6193105 Website

The Crohn's & Colitis Foundation is a leading nonprofit organization dedicated to research and patient support for inflammatory bowel disease (IBD). Headquartered in New York, NY, the Foundation operates as a 501(c)(3) tax-exempt organization that has been recognized by the IRS since July 1966. The organization employs approximately 372-414 staff members and operates chapters across multiple regions, including the Pacific Northwest serving Washington, Oregon, Idaho, Montana, and Alaska.

Financial Overview

From 2024 IRS Form 990-PF · View filing

Total Assets

$50.6M

-6.2% YoY

Annual Giving

$13.0M

-17.1% YoY

Grant Count

75

-1.3% YoY

Avg Grant Size

$173K

-16.0% YoY

Research compiled by Grantable AI from public sources. Last updated April 2026.

Mission & Focus Areas

The Foundation's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults who suffer from these diseases.

The Foundation's work encompasses:

  • Research Funding: Since its inception, the Foundation has provided more than $500 million for research on the treatment and cures of IBD. The research portfolio includes basic, translational, and clinical research initiatives.

  • Priority Research Initiatives: The Foundation funds multi-institutional, multi-disciplinary, collaborative research projects targeting areas of science with a high probability of advancing treatment.

  • IBD Plexus Platform: An innovative research database designed to accelerate the research process. Currently the single largest IBD database in the United States and the most comprehensive IBD database in the world, providing researchers with data from over 30,000 patients, including 250,000 biosamples (blood, stool, and intestinal tissue).

  • Patient Support & Education: Extensive educational resources for patients and their families, medical professionals, and the public.

Grantmaking

The Foundation actively funds research initiatives targeting inflammatory bowel disease. Recent grantmaking activity includes:

Ready to take the next step with Crohn's & Colitis Foundation Inc?

Geographic Focus

Where this funder awards grants

Grant Distribution by State

33states
+25 more states

Cities

AlbanyAllenAnn ArborAtlantaAugustaAuroraBaltimoreBillericaBirminghamBloomingtonBostonBranfordBurlingtonBurnt HillsCambridgeChapel HillCharlotteCharlottesvilleChicagoCincinnati

Financial History

Multi-year comparison from IRS filings

Most Recent (2024):

  • Total Revenues: $85,182,348
  • Total Expenses: $83,504,823
  • Total Assets: $50,647,406

Staffing:

  • 372 employees (2024 filing)
  • 414 employees (alternative source)
Revenue
Expenses
Qualifying Distributions
Net Investment Income
$0$24M$48M$71M$95M20202021202220232024
Metric202420232022
Total Assets$50,647,406$54,000,124$57,441,645
Revenue$85,182,348$81,765,248$81,491,223
Expenses$83,504,823$86,537,979$82,569,900
Qualifying Distributions
Net Investment Income$1,327,009$729,260$-30,834
Distributable Amount

Giving Over Time

Total grant dollars and number of grants per year

$0$5M$9M$14M$18M85 grants202071 grants202159 grants202276 grants202375 grants2024

Grant Insights

How this funder distributes its grants

Top Recipients

Top 10 recipients in 2024

INFINITY BIOLOGIX LLC$662KMOBIUS CARE INC$500KCEDARS SINAI MEDICAL CEN…$426KICAHN SCHOOL OF MEDICINE…$407KCINCINNATI CHILDREN'S HO…$375KMASSACHUSETTS GENERAL HO…$363KRUTGERS THE STATE UNIVER…$316KAETION INC$316KNORTHWESTERN UNIVERSITY …$302KJOHNS HOPKINS UNIVERSITY$300K

Grant Size Distribution

250 grants across all recorded years

51<$50K51$50–100K77$100–250K48$250–500K20$500K–1M3$1–5M$5M+

Open Grants

8 open opportunities from Crohn's & Colitis Foundation Inc

Show all 8 →

Giving History

Grant recipients and amounts by year

No grants recorded for .

Leadership & Key People

Leadership team and compensation from IRS filings

The Foundation maintains a board of directors and regional leadership structure. Key personnel identified include:

  • Regional and Executive Directors across multiple chapters
  • Board members including Johanna Mora (joined December 2025), Kelli A Young, Becky Flaherty, and Paul Ragos

Compensation Overview

From 2024 IRS filing

MICHAEL OSSOPRESIDENT/CEO(NON-VOTING)$604KALAN MOSSCHIEF SCIENTIFIC OFFICER$450KROHIT SURICHIEF TECHNOLOGY OFFICER$305KALLISON COFFEYCHIEF DEVELOPMENT OFFICER$273KSHARON LUNGRINCHIEF OP. OFF./CHIEF FIN.$267KANGELA DOBESVICE PRESIDENT, IBD PLEXUS$259KMARISA MAYERCHIEF LEGAL OFFICER$259KCHRISTY DESANTISCHIEF MKTNG. & COMM. OFFCR.$257KLAURA WINGATECHIEF EDU. SUPP. & ADVOC. OF…$220KCHRIS FIDYKEVP, BUSINESS DEVELOPMENT$214KSARAH WEAVERVP, CLINICAL QUALITY & INNOV…$207KJACK MATARASSOSVP, DIGITAL MARKETING$203KLEANA PATELVP, PEOPLE & CULTURE$202K

From 2024 filing

NameTitleHoursCompensation
MICHAEL OSSOPRESIDENT/CEO(NON-VOTING)35$604,255
DANIEL STONETREASURER1
JODI YELLENSECRETARY (THRU 03/2024)1
JEFFREY MITTLEMANSECRETARY (AS OF 03/2024)1
BRENT POLK MDCHAIRMAN (THRU 03/2024)1
AMBER BACKHAUSCHAIRMAN (AS OF 03/2024)1
RHONDA BOLDINGTRUSTEE1
NOEL BROWNTRUSTEE (AS OF 03/2024)1
JOHN CAPODILUNOTRUSTEE1
CHASE CARPENTERTRUSTEE1
ROCIO CASTRILLONTRUSTEE (AS OF 03/2024)1
DEBORAH CRAWFORDTRUSTEE1
TOLULOPE FALAIYE MDTRUSTEE1
BECKY FLAHERTYTRUSTEE (AS OF 03/2024)1
ALEX FUNDERBURGTRUSTEE (THRU 03/2024)1
CHERYL GUERINTRUSTEE1
KEVIN HARLENTRUSTEE1
PETER HIGGINS MD PHD MSCNSAC CHAIR ELECT1
KELLY ISSOKSON MSRDCNSCTRUSTEE1
SEAN KELLEYTRUSTEE (THRU 03/2024)1
SANDRA KIM MDTRUSTEE (AS OF 03/2024)1
MICHELE KISSOUS-HUNTTRUSTEE (THRU 03/2024)1
ANNETTE MARTINEZTRUSTEE1
AUDRA MILLERTRUSTEE1
JOE MONKTRUSTEE (THRU 03/2024)1
MARK MURRAY PHDTRUSTEE (THRU 03/2024)1
ARMIN RAHMANIANTRUSTEE1
MEGAN RIEHL PSYDTRUSTEE (AS OF 03/2024)1
JONATHAN ROSETRUSTEE (AS OF 07/2024)1
DAVID RUBIN MDTRUSTEE1
FRANK RUSSOMANOTRUSTEE (THRU 03/2024)1
LORI SIEGEL RABINOWITZTRUSTEE1
ANDREW STERNTRUSTEE (AS OF 03/2024)1
NICHOLAS UZLTRUSTEE (THRU 06/2024)1
TROY VOLLERTSENTRUSTEE1
DOUGLAS WOLF MDTRUSTEE (AS OF 03/2024)1
SHARON LUNGRINCHIEF OP. OFF./CHIEF FIN.35$267,379
ALAN MOSSCHIEF SCIENTIFIC OFFICER35$450,466
ROHIT SURICHIEF TECHNOLOGY OFFICER35$304,578
ALLISON COFFEYCHIEF DEVELOPMENT OFFICER35$273,205
CHRIS FIDYKEVP, BUSINESS DEVELOPMENT35$213,952
CHRISTY DESANTISCHIEF MKTNG. & COMM. OFFCR.35$256,701
LAURA WINGATECHIEF EDU. SUPP. & ADVOC. OFFICER35$219,544
SARAH WEAVERVP, CLINICAL QUALITY & INNOVATION35$206,702
ANGELA DOBESVICE PRESIDENT, IBD PLEXUS35$259,396
MARISA MAYERCHIEF LEGAL OFFICER35$259,396
LEANA PATELVP, PEOPLE & CULTURE35$202,086
JACK MATARASSOSVP, DIGITAL MARKETING35$202,684

Contact Information

Subject Areas

Focus areas based on grantmaking activity

Data last updated April 2026. Sourced from IRS Form 990-PF filings. Research dossier generated April 2026.

What could you do with Crohn's & Colitis Foundation Inc on Grantable?

  • Assess strategic fit with your organization
  • Draft a tailored letter of inquiry
  • Find open RFPs from this funder
  • Monitor for new funding opportunities